Essex Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Essex Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,504	Closed	-$207K	–	483
2022 Q1	$207K	Sell	4,504 -248	-5%	-$11.8K	0.02%	472
2021 Q4	$291K	Buy	4,752 +171	+4%	+$11.8K	0.03%	370
2021 Q3	$342K	Buy	4,581 +2,119	+86%	+$178K	0.04%	322
2021 Q2	$218K	Hold	2,462	–	–	0.03%	415
2021 Q1	$218K	Buy	+2,462	New	+$244K	0.04%	325

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Essex Financial Services's ARKG Position: Q2 2022 in Review

Essex Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,504 shares — an estimated $207K sold.

Essex Financial Services first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $342K in Q3 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Essex Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Essex Financial Services sold 4,504 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $207K.
Essex Financial Services first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
Essex Financial Services's ARK Genomic Revolution ETF position peaked at $342K in Q3 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Essex Financial Services's 13F filing for Q2 2022, filed 1 Aug 2022.